Sort
39,280 grants matching “leukemia”
Project 3 - Genomics of Secondary AML Progression.
$430,870Matthew J Walter · Washington University · P01 · FY2022 · CA
Targeting TET1 signaling to treat acute myeloid leukemia
$430,865Jianjun Chen · University Of Cincinnati · R01 · FY2017 · CA
Role of MELK in glioblastomas
$430,850Alexey V Terskikh · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · NS
Structural basis of Jak3-mediated interleukin-2 family signal transduction
$430,831Titus Jonathon Boggon · Yale University · R01 · FY2011 · AI
Occupational Exposure Assessment
$430,819Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Bmi-1 and Skin Cancer Prevention
$430,818Richard L Eckert · University Of Maryland Baltimore · R01 · FY2010 · CA
Synthetic Studies Related to Cancer Research/Treatment
$430,815Paul Wender · Stanford University · R01 · FY2023 · CA
Project 1 BCL11A Protein in Hemoglobin Regulation, Stuart H. Orkin
$430,810Stuart H Orkin · Boston Children'S Hospital · P01 · FY2021 · HL
Project 1 BCL11A Protein in Hemoglobin Regulation, Stuart H. Orkin
$430,810Stuart H Orkin · Boston Children'S Hospital · P01 · FY2019 · HL
Project 1 BCL11A Protein in Hemoglobin Regulation, Stuart H. Orkin
$430,810Stuart H Orkin · Boston Children'S Hospital · P01 · FY2020 · HL
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$430,781Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting Tumor Suppressive Pathways for Cancer Therapy
$430,779Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R35 · FY2015 · CA
Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting
$430,769Daniel T Chiu · University Of Washington · UG3 · FY2018 · CA
Synthetic Studies Related to Cancer Research/Treatment
$430,697Paul Wender · Stanford University · R01 · FY2025 · CA
Molecular Pathogenesis of Fanconi Anemia
$430,696Alan David D'andrea · Dana-Farber Cancer Inst · R01 · FY2023 · HL
EASTERN COOPERATIVE ONCOLOGY GROUP
$430,690Vanderbilt University · U10 · FY2003 · CA
Enhancing neutrophil function in neutropenia-related pneumonia
$430,650Hongbo R Luo · Boston Children'S Hospital · R01 · FY2012 · HL
Niche-induced Signaling in Progenitor B Cell Development
$430,650Leslie Eric Silberstein · Boston Children'S Hospital · R01 · FY2012 · HL
Abnormal Stem Cell Trafficking in IM
$430,631Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · CA
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$430,560Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · CA
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
$430,489Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
$430,442William L. Carroll · New York University School Of Medicine · R01 · FY2025 · CA
What fuels CAR T-cell serial killing
$430,406Roderick O'Connor · University Of Pennsylvania · R01 · FY2023 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$430,377Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA